Caribou Biosciences Inc (CRBU)
2.885
+0.04
(+1.23%)
USD |
NASDAQ |
May 31, 16:00
2.885
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Price: 2.885 for May 31, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 31, 2024 | 2.91 | 2.98 | 2.86 | 2.885 | 1.297M |
| May 30, 2024 | 2.91 | 2.94 | 2.795 | 2.85 | 1.552M |
| May 29, 2024 | 2.92 | 2.95 | 2.775 | 2.88 | 2.086M |
| May 28, 2024 | 3.00 | 3.06 | 2.94 | 2.99 | 1.474M |
| May 24, 2024 | 3.03 | 3.05 | 2.95 | 2.97 | 1.533M |
| May 23, 2024 | 3.11 | 3.12 | 2.975 | 3.01 | 2.725M |
| May 22, 2024 | 3.10 | 3.19 | 2.98 | 3.11 | 2.673M |
| May 21, 2024 | 3.13 | 3.14 | 2.98 | 3.09 | 3.669M |
| May 20, 2024 | 3.41 | 3.45 | 3.01 | 3.13 | 7.586M |
| May 17, 2024 | 3.60 | 3.640 | 3.365 | 3.39 | 2.515M |
| May 16, 2024 | 3.66 | 3.72 | 3.52 | 3.59 | 1.766M |
| May 15, 2024 | 3.75 | 3.835 | 3.62 | 3.64 | 2.469M |
| May 14, 2024 | 3.82 | 3.91 | 3.625 | 3.64 | 1.461M |
| May 13, 2024 | 3.60 | 3.915 | 3.60 | 3.71 | 2.382M |
| May 10, 2024 | 3.67 | 3.80 | 3.521 | 3.54 | 1.001M |
| May 09, 2024 | 3.50 | 3.695 | 3.50 | 3.65 | 1.508M |
| May 08, 2024 | 3.64 | 3.70 | 3.44 | 3.50 | 2.406M |
| May 07, 2024 | 3.88 | 3.89 | 3.685 | 3.73 | 1.237M |
| May 06, 2024 | 3.85 | 3.93 | 3.76 | 3.83 | 1.572M |
| May 03, 2024 | 3.77 | 3.90 | 3.69 | 3.77 | 1.817M |
| May 02, 2024 | 3.75 | 3.82 | 3.56 | 3.64 | 2.349M |
| May 01, 2024 | 3.65 | 3.85 | 3.61 | 3.69 | 1.740M |
| Apr 30, 2024 | 3.76 | 3.76 | 3.61 | 3.63 | 1.473M |
| Apr 29, 2024 | 3.74 | 3.895 | 3.71 | 3.78 | 1.477M |
| Apr 26, 2024 | 3.90 | 3.90 | 3.69 | 3.71 | 1.045M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.85
Minimum
May 30 2024
30.29
Maximum
Sep 07 2021
9.229
Average
7.13
Median
Jan 30 2023
Price Benchmarks
| Guardant Health Inc | 27.10 |
| Regeneron Pharmaceuticals Inc | 980.59 |
| Sangamo Therapeutics Inc | 0.5599 |
| Vertex Pharmaceuticals Inc | 455.34 |
| Regulus Therapeutics Inc | 2.27 |
Price Related Metrics
| PS Ratio | 6.976 |
| Price to Book Value | 0.759 |
| Earnings Yield | -50.61% |
| Market Cap | 260.57M |